We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEAC
3276
DELISTED
Seachange International Inc
SEAC
-133
Closed -$4K
APTX
3277
DELISTED
Aptinyx Inc. Common Stock
APTX
-2,169
Closed -$7K
LMST
3278
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
-446
Closed -$7K
AGRX
3279
DELISTED
Agile Therapeutics
AGRX
-3
Closed -$12K
AGFS
3280
DELISTED
AgroFresh Solutions Inc
AGFS
-2,627
Closed -$5K
ASPU
3281
DELISTED
ASPEN GROUP, INC.
ASPU
-1,639
Closed -$10K
ALR
3282
DELISTED
AlerisLife Inc
ALR
-1,669
Closed -$10K
CNCE
3283
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-2,332
Closed -$12K
LHDX
3284
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-850
Closed -$10K
MTCR
3285
DELISTED
Metacrine, Inc. Common Stock
MTCR
-555
Closed -$3K
LCI
3286
DELISTED
Lannett Company, Inc.
LCI
-598
Closed -$13K
ASAP
3287
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
-331
Closed -$19K
PFHD
3288
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
-980
Closed -$18K
TCDA
3289
DELISTED
Tricida, Inc. Common Stock
TCDA
-2,498
Closed -$13K
BIOR
3290
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
-1
Closed -$1K
SCPS
3291
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
-450
Closed -$4K
ELOX
3292
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
-56
Closed -$7K
AGTC
3293
DELISTED
Applied Genetic Technologies Corporation
AGTC
-3,532
Closed -$18K
LOGC
3294
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
-670
Closed -$5K
FNHC
3295
DELISTED
FedNat Holding Company Common Stock
FNHC
-1,014
Closed -$5K
CYBE
3296
DELISTED
Cyberoptics Corp
CYBE
-621
Closed -$16K
PHAS
3297
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-1,211
Closed -$4K
EXTN
3298
DELISTED
Exterran Corporation
EXTN
-2,624
Closed -$9K
BRG
3299
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
-2,019
Closed -$20K
TYME
3300
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
-6,120
Closed -$11K

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.